Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
31 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a biopharmaceutical company that develops novel products and tools in fields of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its products include single cell WGA kits, WGA kits, RCA kit, one step RT-PCR kit, one step RT-qPCR kit, and others. Sygnis offers products such as single cell reverse transcriptase RNaseH+ and RNaseH-. The companys single cell WGA kit is based on its proprietary primpol technology. Its products are also based on retrotranscriptase technology. The company has presence in Germany and Spain.

Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Det

  
Source:
Document ID
GDPH81796D
Country
Industry
Ticker
LIO1=DE
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sygnis AG, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sygnis AG, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sygnis AG, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sygnis AG, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Sygnis AG, Medical Devices Deals, 2010 to YTD 201691
Sygnis AG, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Sygnis AG, Pharmaceuticals &Healthcare, Deal Details1117
  Partnerships111
    Cenix BioScience Enters Into Research Agreement With Sygnis Bioscience111
  Licensing Agreements121
    Thermo Fisher Scientific Enters into Licensing Agreement with Sygnis121
    Sygnis Enters Into Licensing Agreement With Systasy131
    Sygnis Pharma Enters Into Licensing Agreement With Qiagen For Amplification Buffer141
    SYGNIS Pharma Enters Into Licensing Agreement For European Patent151
  Equity Offering161
    Sygnis Raises USD23 Million in Rights Offering of Shares162
    Sygnis Raises USD6 Million in Rights Offering of Shares182
    Sygnis Raises USD6.2 Million in Rights Offering202
    Sygnis Completes Rights Offering Of Shares For US$4.2 Million221
    SYGNIS Pharma Completes Rights Issue Of Common Stock For US$0.21 Million232
  Acquisition251
    Sygnis Plans to Acquire Expedeon251
    Sygnis Pharma Completes Acquisition Of X-Pol Biotech In Reverse Takeover Transaction262
Sygnis AG - Key Competitors281
Key Employees291
Locations And Subsidiaries301
  Head Office301
  Other Locations &Subsidiaries301
Appendix311
  Methodology311
  About GlobalData311
  Contact Us311
  Disclaimer311

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sygnis-AG-LIO1-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7767>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sygnis AG (LIO1) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sygnis-AG-LIO1-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7767>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research